Faced with thou­sands of opi­oid law­suits, En­do says it will like­ly file for bank­rupt­cy 'im­mi­nent­ly'

En­do In­ter­na­tion­al will like­ly be the next phar­ma com­pa­ny to file for bank­rupt­cy un­der a moun­tain of opi­oid law­suits.

The Dublin, Ire­land-based com­pa­ny re­vealed in its Q2 re­sults on Tues­day that it’s in talks with first lien cred­i­tors, and that “these ne­go­ti­a­tions will like­ly re­sult in a pre-arranged fil­ing un­der Chap­ter 11 of the U.S. Bank­rupt­cy Code by En­do In­ter­na­tion­al plc and sub­stan­tial­ly all of its sub­sidiaries, which could oc­cur im­mi­nent­ly.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER